If nasal polyps grow large enough or multiply, they can block airflow and drainage in the nasal passages, potentially leading ...

“If your nasal polyps get to a phase in which you have a very large and significant polyp load, it’s very hard to get them to go away,” she says. Treatment and Medication Options for Nasal ...

may be recommended if nonsurgical treatments are ineffective or if the nasal polyps are very large. This typically is an ...

Nasal polyps can also cause a runny nose. Nasal polyps can affect a person’s ability to smell. This happens when polyps are large enough to become obstructive, or block the nasal passageways.

What you may think are allergies or a cold, could be the sign of nasal polyps. Nasal polyps are non-cancerous growths that line the nasal passages and sinuses. They are soft, painless, and hang ...

Nasal polyps are small noncancerous growths in the nose or sinuses. They may cause pain or pressure in the face, runny or stuffy nose, and other symptoms or complications that may negatively ...

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

Both trials met their co-primary endpoints of a change from baseline in total endoscopic nasal polyp score at 52 weeks and a change from baseline in mean nasal obstruction score from weeks 49 to 52.

A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.

The following is a summary of “Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR),” published in the October 2024 issue of Allergy and Immunology by Seys et al. Pivotal ...

The drug improved both the size of nasal polyps at week 52 and in nasal obstruction ... In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies ...

Statistically Significant Reduction in Nasal Polyp Size, Nasal Congestion Compared to Placebo THOUSAND OAKS, Calif., Nov. 7, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) ...